MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production

Y Mok, V Schwierzeck, DC Thomas… - The Journal of …, 2013 - journals.aai.org
Y Mok, V Schwierzeck, DC Thomas, E Vigorito, TF Rayner, LB Jarvis, HM Prosser, A Bradley
The Journal of Immunology, 2013journals.aai.org
MicroRNAs (MiRs) are small, noncoding RNAs that regulate gene expression
posttranscriptionally. In this study, we show that MiR-210 is induced by Oct-2, a key
transcriptional mediator of B cell activation. Germline deletion of MiR-210 results in the
development of autoantibodies from 5 mo of age. Overexpression of MiR-210 in vivo
resulted in cell autonomous expansion of the B1 lineage and impaired fitness of B2 cells.
Mice overexpressing MiR-210 exhibited impaired class-switched Ab responses, a finding …
Abstract
MicroRNAs (MiRs) are small, noncoding RNAs that regulate gene expression posttranscriptionally. In this study, we show that MiR-210 is induced by Oct-2, a key transcriptional mediator of B cell activation. Germline deletion of MiR-210 results in the development of autoantibodies from 5 mo of age. Overexpression of MiR-210 in vivo resulted in cell autonomous expansion of the B1 lineage and impaired fitness of B2 cells. Mice overexpressing MiR-210 exhibited impaired class-switched Ab responses, a finding confirmed in wild-type B cells transfected with a MiR-210 mimic. In vitro studies demonstrated defects in cellular proliferation and cell cycle entry, which were consistent with the transcriptomic analysis demonstrating downregulation of genes involved in cellular proliferation and B cell activation. These findings indicate that Oct-2 induction of MiR-210 provides a novel inhibitory mechanism for the control of B cells and autoantibody production.
journals.aai.org